Revolution Medicines (RVMD) Other Non-Current Assets (2019 - 2026)

Revolution Medicines has reported Other Non-Current Assets for 8 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 63.01% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (down 63.01% YoY), and the FY2025 full-year result was $24.1 million, up 1286.22% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $4.9 million, down from $24.1 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $31.4 million in Q2 2025, with the low at $851000.0 in Q1 2022.
• Average Other Non-Current Assets over 5 years is $7.7 million, with a median of $4.9 million recorded in 2025.
• Year-over-year, Other Non-Current Assets sank 75.23% in 2024 and jumped 1286.22% in 2025.
• Tracing RVMD's Other Non-Current Assets over 5 years: stood at $1.7 million in 2022, then surged by 304.84% to $7.0 million in 2023, then slumped by 75.23% to $1.7 million in 2024, then jumped by 1286.22% to $24.1 million in 2025, then tumbled by 79.88% to $4.9 million in 2026.
• The last three Other Non-Current Assets figures came in at $4.9 million (Q1 2026), $24.1 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.

Peer Comparison